A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled
Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in
Subjects with Non-Alcoholic Steatohepatitis (NASH)
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled
Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in
Subjects with Non-Alcoholic Steatohepatitis (NASH)
© 2021 Latin Clinical Trial Center.
All Rights Reserved.
Powered By Millennial Networks